A potential drug successfully treats the severe form of nonalcoholic fatty liver disease in non-human primates bringing scientists one step closer to the first human treatment for the condition that is rapidly increasing around the world, a study suggests. Nonalcoholic steatohepatitis (NASH) causes scarring and inflammation in the liver and is estimated to affect up to 6.5% of the global population.
Researchers identify hormone from fat cells that restrains tumor growth in mice
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Researchers identify hormone from fat cells that restrains tumor growth in mice
umich.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from umich.edu Daily Mail and Mail on Sunday newspapers.